You are in:Home/Publications/Serum Interleukin-6 Concentration Associated with Response to Therapy for Chronic Hepatitis C Patients | |
Prof. Naglaa El-Toukhy Ramadan El-Toukhy :: Publications: |
Title: | Serum Interleukin-6 Concentration Associated with Response to Therapy for Chronic Hepatitis C Patients |
Authors: | Amal Ahmed Mohamed, Naglaa El-Toukhy, Ehab M Reyad, Noha Abd El Rahman El Desoky |
Year: | 2017 |
Keywords: | Not Available |
Journal: | Journal of Gastroenterology and Hepatology Research |
Volume: | 6 |
Issue: | Not Available |
Pages: | 2405-2410 |
Publisher: | Not Available |
Local/International: | International |
Paper Link: | Not Available |
Full paper | Naglaa El-Toukhy Ramadan El-Toukhy_8 IL 6 and INF.pdf |
Supplementary materials | Not Available |
Abstract: |
INTRODUCTION: Egypt has the highest prevalence of (HCV) in the world. Interleukin 6 is a pleiotropic cytokine that increased in chronic hepatitis C patients. IL-6 was suggested by several studies to play a major role in response to HCV therapy. AIM: The aim of this work was to assess the possible role of IL-6 on response status of patients with HCV during treatment. Also we try to use IL-6 as a p |